Delivery Order SPE2DB20D3303-SPE2DB25FY8B7

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,401.79, is for the delivery of Lamotrigine ODT 100 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing model. The contract has a period of performance through November 7, 2024 and was awarded on November 6, 2024. There was no set-aside designation for this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lamotrigine ODT 50 mg tablets. The $1,792.28 firm fixed-price contract is a delivery order under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4560864186 - LAMOTRIGINE ODT 200 MG TABLET 30S. The contract has a ceiling value of $3,497.89 and a completion date of May 9, 2023. It is a Firm Fixed Price contract type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,140.95 Firm Fixed Price Delivery Order is for the supply of Lamotrigine ER 300 mg tablets. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ER 25 mg tablets. The $1,990.68 firm fixed-price contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $2,992.38, is for the delivery of Lamotrigine ER 300 mg Tablets in 30-count packages. This is a firm fixed price delivery order contract with an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,188.31 Firm Fixed Price delivery order is for the supply of 4566748541 - Lamotrigine ER 250 mg tablets. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,893.38 firm-fixed-price delivery order is for the supply of 4565353577 - Lamotrigine Extended-Release 300 mg Tablets in 30-count packages. The award has an ultimate completion date of August 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by DLA and other federal agencies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,930.54, is a Firm Fixed Price Delivery Order for the supply of Lamotrigine ER 50 mg tablets. The contract has an ultimate completion date of May 5, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 200 mg Tablets in quantities of 30. The $3,349.80 contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of August 18, 2022 and was awarded on August 17, 2022. The contract is not designated with a set-aside requirement, indicating open competition....
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FY8B7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,776.00 fixed-price delivery order contract is for 4566893159 LAMOTRIGINE ODT 100 MG TABLET 30S, with a performance period ending on January 13, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award did not have a set-aside designation, indicating open competition. The contract demonstrates Amerisourcebergen's expertise in supplying a wide array of medical commodities, including specialty medications, generic drugs, and other essential pharmaceutical and medical supplies, to federal agencies and military healthcare facilities.

Generated 4/13/25, 12:44 AM